Central diabetes insipidus and pain medications – a risky combination
Abstract Background Central Diabetes Insipidus (CDI) results from decreased production of antidiuretic hormone (ADH) leading to an inability to concentrate urine. CDI is treated with desmopressin (DDAVP). Rarely reported in the literature, opioids and non-steroidal anti-inflammatories (NSAIDs) can i...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Clinical Diabetes and Endocrinology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40842-021-00124-9 |